Literature DB >> 8710500

Characterization of several kinds of dimer minizyme: simultaneous cleavage at two sites in HIV-1 tat mRNA by dimer minizymes.

T Kuwabara1, S V Amontov, M Warashina, J Ohkawa, K Taira.   

Abstract

A minizyme is a hammerhead ribozyme with short oligonucleotide linkers instead of stem-loop II. In a previous study we demonstrated that a minizyme with high activity forms a dimeric structure with a common stem II. Because of their dimeric structure, minizymes are potentially capable of cleaving a substrate at two different sites simultaneously. In order to examine the properties of different kinds of minizyme, we constructed a number of minizymes with short oligonucleotide linkers (2-5 bases) instead of stem-loop II and examined their cleavage activities against HIV-1 tat mRNA. Analyses of melting curves, as well as Arrhenius plots, revealed that, in general, the longer the oligonucleotide linkers, the more stable and more active were the dimer minizymes. All minizymes examined cleaved the target substrate at two sites simultaneously. The activity of the dimer minizyme with a 5 nt linker was higher than that of the parental hammerhead ribozyme because the latter full-sized ribozyme was able to cleave at one site only.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8710500      PMCID: PMC145929          DOI: 10.1093/nar/24.12.2302

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

1.  Extended target-site specificity for a hammerhead ribozyme.

Authors:  R Perriman; A Delves; W L Gerlach
Journal:  Gene       Date:  1992-04-15       Impact factor: 3.688

2.  Ribozymes that cleave an RNA sequence from human immunodeficiency virus: the effect of flanking sequence on rate.

Authors:  J Goodchild; V Kohli
Journal:  Arch Biochem Biophys       Date:  1991-02-01       Impact factor: 4.013

3.  Kinetic characterization of intramolecular and intermolecular hammerhead RNAs with stem II deletions.

Authors:  D M Long; O C Uhlenbeck
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

4.  Enhancement of the cleavage rates of DNA-armed hammerhead ribozymes by various divalent metal ions.

Authors:  S Sawata; T Shimayama; M Komiyama; P K Kumar; S Nishikawa; K Taira
Journal:  Nucleic Acids Res       Date:  1993-12-11       Impact factor: 16.971

5.  In vitro activity of minimised hammerhead ribozymes.

Authors:  P Hendry; M J McCall; F S Santiago; P A Jennings
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

6.  RNA enzyme-directed gene therapy.

Authors:  S Altman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

7.  Nuclease-resistant chimeric ribozymes containing deoxyribonucleotides and phosphorothioate linkages.

Authors:  T Shimayama; F Nishikawa; S Nishikawa; K Taira
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

8.  Incorporation of the catalytic domain of a hammerhead ribozyme into antisense RNA enhances its inhibitory effect on the replication of human immunodeficiency virus type 1.

Authors:  M Homann; S Tzortzakaki; K Rittner; G Sczakiel; M Tabler
Journal:  Nucleic Acids Res       Date:  1993-06-25       Impact factor: 16.971

9.  Kinetics of intermolecular cleavage by hammerhead ribozymes.

Authors:  M J Fedor; O C Uhlenbeck
Journal:  Biochemistry       Date:  1992-12-08       Impact factor: 3.162

10.  Effects of deoxyribonucleotide substitutions in the substrate strand on hammerhead ribozyme-catalyzed reactions.

Authors:  T Shimayama
Journal:  Gene       Date:  1994-11-04       Impact factor: 3.688

View more
  6 in total

1.  Small, efficient hammerhead ribozymes.

Authors:  M J McCall; P Hendry; A A Mir; J Conaty; G Brown; T J Lockett
Journal:  Mol Biotechnol       Date:  2000-01       Impact factor: 2.695

2.  Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA.

Authors:  T Kuwabara; M Warashina; T Tanabe; K Tani; S Asano; K Taira
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

3.  Effects of helical structures formed by the binding arms of DNAzymes and their substrates on catalytic activity.

Authors:  N Ota; M Warashina; K Hirano; K Hatanaka; K Taira
Journal:  Nucleic Acids Res       Date:  1998-07-15       Impact factor: 16.971

4.  Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymes targeted to cleave HIV-1 TAT/Rev RNA.

Authors:  H Unwalla; A C Banerjea
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

5.  tRNAVal-heterodimeric maxizymes with high potential as geneinactivating agents: simultaneous cleavage at two sites in HIV-1 Tat mRNA in cultured cells.

Authors:  T Kuwabara; M Warashina; A Nakayama; J Ohkawa; K Taira
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 6.  Anti-HIV ribozymes.

Authors:  L Q Sun; J A Ely; W Gerlach; G Symonds
Journal:  Mol Biotechnol       Date:  1997-06       Impact factor: 2.860

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.